Clinical trial
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and…
NCT00454883 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00454883 |
|---|---|
| Title | Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders. |
| Official title | Treatment Of Manic Or Mixed Episodes Of Up To Moderate Severity In Patients With Bipolar Disorder And Schizoaffective Disorder |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Affective Psychosis, Bipolar, Mania, Manic-Depressive Psychosis |
| Intervention type | Drug |
| Interventions | ziprasidone |
| Enrollment | 379 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 2, 2007 |
| Last update posted | Feb 21, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: